Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women. - Test2 - elhamkhani - TriplyDB

Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women.

Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women.

http://www.wikidata.org/entity/Q35102123

about

Hormonal Contraceptives Differentially Suppress TFV and TAF Inhibition of HIV Infection and TFV-DP in Blood and Genital Tract CD4+ T cells.

P2860

Q47151161-5AFE3EBB-5A68-4D11-AFEF-182CF56DCB9E

P2860

Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women.

http://www.wikidata.org/entity/Q35102123

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Immunologic, virologic, and ph ...... l tract in HIV-infected women.

@ast

Immunologic, virologic, and ph ...... l tract in HIV-infected women.

@en

type

label

Immunologic, virologic, and ph ...... l tract in HIV-infected women.

@ast

Immunologic, virologic, and ph ...... l tract in HIV-infected women.

@en

prefLabel

Immunologic, virologic, and ph ...... l tract in HIV-infected women.

@ast

Immunologic, virologic, and ph ...... l tract in HIV-infected women.

@en

P1433

Q35102123-2144D3EF-5621-4809-B050-87802D82C809

P1476

Q35102123-C80CC39E-9C87-48AF-A2B5-0188B62B49C6

P2093

Q35102123-0114147D-FA35-49D4-9452-97804073B463

Q35102123-316862CB-9369-4E89-B823-33A6DF1DA219

Q35102123-4F880030-BE27-4726-A003-0271F8EB34D5

Q35102123-67E65BE8-0604-4B98-9A2B-60F2FEAED2E1

Q35102123-6F895548-1774-4C81-92A7-638C1625450F

Q35102123-89D29561-7C1E-4C78-941A-5EB9B8EDD500

Q35102123-94D93892-9689-4A6B-81CC-7AC708647A8E

Q35102123-A178A35E-9273-467A-ADBA-806F68757ED6

Q35102123-E4F75E51-B716-4E0D-A68E-A3FBBB7116AB

Q35102123-EE4F1CFD-184C-40F4-85D3-5C62BDE8993C

P2860

Q35102123-03C8223C-7239-4140-B6C5-03D3DDD04399

Q35102123-079F4710-28C4-42C2-BD27-017B3B8D021C

Q35102123-1596AAFF-222A-4202-BFF2-98D53C3476BC

Q35102123-1A062789-47D9-4A9F-9F1D-B17663DB4940

Q35102123-2CF25F9A-2939-4599-9172-F3C464008EB2

Q35102123-2DBB225E-6E43-4CFC-9A4A-AFBCA241CECC

Q35102123-32165A5C-34E5-4AC7-B3CF-A5F814422E26

Q35102123-37FCB07B-E80E-4AFE-8CF8-D7DC90D81C53

Q35102123-3BCC2473-8B3A-41D7-BED6-97613DE3A3D4

Q35102123-3C5B78E9-8748-4C6B-B4A9-7A225C6240E8

P304

Q35102123-C3481748-E22B-4C03-B1E2-E49AA03FE1FA

P31

Q35102123-CC02C9B6-EFB9-4FA6-9EB8-684E1514B381

P356

Q35102123-08F48FA8-21BE-44DE-A022-7BE0D57AC5B6

P407

Q35102123-BED55D84-09CC-4BC4-9835-F74CF7C69A63

P433

Q35102123-A902C372-D989-44C7-AAE0-546CCA4F874A

P478

Q35102123-6958BEF9-6B6B-4083-84E6-48DFB26DB7E4

P50

Q35102123-21C05546-3E28-4AD1-B280-929FCD15BFB7

P577

Q35102123-3AFF0D0B-D0A5-45F6-893B-4135E05624BE

P698

Q35102123-142AAA44-07F0-4F52-9B85-D3771E8642C3

P921

Q35102123-5733CA6D-0B15-4A1A-B077-58D28E15EDD3

P932

Q35102123-78A50D9B-773F-4410-BF48-F440FE6D4C95

P356

QAI.0000000000000480

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Immunologic, virologic, and ph ...... l tract in HIV-infected women.

@en

P2093

Angela D M Kashuba

http://www.w3.org/2001/XMLSchema#string

Cindi Emerson

http://www.w3.org/2001/XMLSchema#string

Craig Sykes

http://www.w3.org/2001/XMLSchema#string

Julie A E Nelson

http://www.w3.org/2001/XMLSchema#string

Kristina De Paris

http://www.w3.org/2001/XMLSchema#string

Kristine B Patterson

http://www.w3.org/2001/XMLSchema#string

Lisa Rahangdale

http://www.w3.org/2001/XMLSchema#string

Mackenzie Cottrell

http://www.w3.org/2001/XMLSchema#string

Steven L Young

http://www.w3.org/2001/XMLSchema#string

Trenton Stevens

http://www.w3.org/2001/XMLSchema#string

P2860

Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role

MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments

Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus

Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system.

HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.

Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry.

Single and multiple dose pharmacokinetics of dolutegravir in the genital tract of HIV-negative women.

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis

Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.

P304

420-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0000000000000480

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25501615

http://www.w3.org/2001/XMLSchema#string

P921

P932

4334681

http://www.w3.org/2001/XMLSchema#string